Immunome Inc

IMNM

Healthcare|Biotechnology|USA

$23.35

-0.82 (-3.39%)

Tangible Book

$5.20

Upcoming Data Readouts (3)

May 2028

Est. completion

P1Solid Malignancies

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Jan 2029

Est. completion

P1Colorectal Cancer

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Dec 2029

Est. completion

Early P1Solid Malignancies

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

Trials past primary completion date but still active — data readout may be imminent.

Dec 2025

P2P3

A Study of AL102 in Patients With Progressing Desmoid Tumors